Peptide record

TPDB20823

Antibacterial Toxicity standard
19 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB20823
Antibacterial Toxicity
Anti-infective peptides Toxicity and safety peptides
Peptipedia
standard
No
A 19-aa standard natural multi-activity (Antibacterial and Toxicity) peptide sequence curated from Peptipedia, with an available 3D structural model.
Sequence
GWLDIAKKVASVVAGLGKR
Physicochemical Analysis
C90H154N26O23
NCEQHMFPTY
AGKV
1968.37
10.83
4
1
10
+3
1.59
0.395
123.16
Mammalian: 30 hour Yeast: >20 hour E.coli: >10 hour
5500
279.42
1
Residue Composition
number
3
A
1
R
0
N
1
D
0
C
0
E
0
Q
3
G
0
H
1
I
2
L
3
K
0
M
0
F
0
P
1
S
0
T
1
W
0
Y
3
V
Amino Acid Distribution
A: 3 R: 1 N: 0 D: 1 C: 0 E: 0 Q: 0 G: 3 H: 0 I: 1 L: 2 K: 3 M: 0 F: 0 P: 0 S: 1 T: 0 W: 1 Y: 0 V: 3
Chemical Descriptors
19
C90H154N26O23
1968.37
10.83
+3
1.59
0.395
Evidence Records 4 records
Evidence 1 Activity

Activity

MIC
Antibacterial
4-8 µg/mL

Target

Escherichia coli ATCC 25922

Source & Reference

NA

Other

Active against E. coli ATCC 25922 (MIC 4-8 ug/ml), S. enteritidis (MIC 64-128 ug/ml), and S. aureus ATCC 29213 (MIC 64 ug/ml).
Evidence 2 Activity

Activity

MIC
Antibacterial
64-128 µg/mL

Target

S. enteritidis

Source & Reference

NA

Other

Active against E. coli ATCC 25922 (MIC 4-8 ug/ml), S. enteritidis (MIC 64-128 ug/ml), and S. aureus ATCC 29213 (MIC 64 ug/ml).
Evidence 3 Activity

Activity

MIC
Antibacterial
64 µg/mL

Target

Staphylococcus aureus ATCC 29213

Source & Reference

NA

Other

Active against E. coli ATCC 25922 (MIC 4-8 ug/ml), S. enteritidis (MIC 64-128 ug/ml), and S. aureus ATCC 29213 (MIC 64 ug/ml).
Evidence 4 Activity

Activity

50% Hemolysis
Toxicity
>128 µg/mL
Hemolytic Cytotoxic
50% Hemolysis | >128 | µg/mL | target cell: Pig erythrocytes

Target

Pig erythrocytes

Source & Reference

NA
DBAASP
Associating Biological Activity and Predicted Structure of Antimicrobial Peptides from Amphibians and Insects | Antibiotics (Basel) | 2022